The storied success of Viagra has undeniably shaped the drug landscape. However, putting money in companies heavily dependent on biosimilars and the diminishing patent rights surrounding this flagship https://adsbookmark.com/story21483221/the-blue-pill-and-pharmaceutical-companies-a-risky-opportunity